Related Articles
Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Identification of responders incorporating the age factor
Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study
Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients